Serum Erythropoietin as Prognostic Marker in Myelodysplastic Syndromes
Acta medica portuguesa(2015)
Abstract
This study suggests that increased erythropoietin levels at diagnosis can by itself be a poor prognosis factor inmyelodysplastic syndromes patients, with higher values in patients with progression to acute leukaemia and decreased overall survival.
MoreTranslated text
Key words
Erythropoietin,Myelodysplastic Syndromes,Prognosis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined